These transcriptomics analyses show that ECM organization is one of the prominent and shared pathways between RQ4 and BLM KO glioma cells, while RECQL4 deficiency has a stronger impact on the cell cycle than BLM deficiency. This evidence concerns the gene BLM and central nervous system cancer.